Trial Profile
A Study to Evaluate the Effects of Dalfampridine on Additional Aspects of Gait and Dexterity in Patients With Multiple Sclerosis Who were Timed Walk Responders and Non Responders
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2016
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 12 Jul 2016 New trial record